Kymera Therapeutics, Inc. (KYMR) › Weighted Average Diluted SharesKymera Therapeutics, Inc. (KYMR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 17.35M2021-12-31: 47.99M2022-12-31: 53.93M2023-12-31: 58.37M2024-12-31: 75.04M2025-12-31: 84.49M84.49M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3184.49M+12.6%2026-02-26From 2025-01-012024-12-3175.04M+28.6%2026-02-26From 2024-01-012023-12-3158.37M+8.2%2026-02-26From 2023-01-012022-12-3153.93M+12.4%2025-02-27From 2022-01-012021-12-3147.99M+176.6%2024-02-22From 2021-01-012020-12-3117.35M—2023-02-23From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)